Hydrokortison Tiofarma

Hydrocortisone, the active ingredient in Hydrokortison Tiofarma, is a corticosteroid (glucocorticoid) presented as an oral dosage form for systemic use. It is employed to replace deficient cortisol in adrenal insufficiency and to modulate immune‑mediated inflammation in various disorders. GNH USA supplies Hydrokortison Tiofarma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Hydrocortisone acts on the hypothalamic‑pituitary‑adrenal axis and immune pathways, providing hormone replacement and anti‑inflammatory effects. - Adrenal insufficiency: restores physiologic cortisol levels and prevents adrenal crisis. - Congenital adrenal hyperplasia: supplies glucocorticoid needed to suppress excess androgen production. - Inflammatory and autoimmune disorders: reduces inflammation and immune activity in conditions such as rheumatoid arthritis or ulcerative colitis.

Hydrocortisone may cause a range of adverse reactions, from mild to severe, depending on dose and duration of therapy.

Common Side Effects: - Increased appetite or weight gain - Fluid retention and mild edema - Elevated blood glucose levels - Mood changes such as irritability or euphoria - Gastrointestinal discomfort or dyspepsia - Minor skin thinning or bruising

Serious or Rare Side Effects: - Severe infection due to immunosuppression - Osteoporosis or pathological fractures - Adrenal suppression on abrupt discontinuation - Hypertension or cardiovascular events - Psychiatric disturbances including psychosis - Allergic reactions such as rash or anaphylaxis

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for potential complications. - Assess adrenal function: confirm diagnosis of insufficiency before replacement. - Screen for infections: avoid use in uncontrolled systemic infections. - Monitor glucose: patients with diabetes may require dose adjustments. - Evaluate bone health: long‑term use can reduce bone mineral density. - Review concomitant medications: potential for drug interactions. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Hydrocortisone can influence the pharmacokinetics or pharmacodynamics of several agents, requiring clinical vigilance.

Major Interactions (Avoid): - CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): may increase systemic exposure. - Anticoagulants (e.g., warfarin): enhanced anticoagulant effect, risk of bleeding. - Live vaccines: immunosuppression may reduce vaccine efficacy and increase infection risk.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): additive risk of gastrointestinal ulceration. - Diuretics: may potentiate hypokalemia. - Antidiabetic agents: glucocorticoid‑induced hyperglycemia may require dose adjustments.